1489 West Warm Springs Road
Suite 110
Henderson, NV 89014
United States
646 650 1351
https://www.volition.com
Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 110
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Martin Charles Faulkes Ph.D. | Executive Chairman | 239,51k | N/A | 1944 |
Mr. Cameron Reynolds MBA | Founder, CEO, President & Director | 572,43k | N/A | 1971 |
Dr. Gaetan Michel Ph.D. | Chief Operating Officer | 518,15k | N/A | 1974 |
Dr. Salvatore Thomas Butera DVM | Chief Executive Officer of Volition Veterinary Diagnostics Development LLC | 477,25k | N/A | 1952 |
Mr. Terig Hughes | CFO & Treasurer | 338,74k | N/A | 1971 |
Dr. Jacob Vincent Micallef MBA, Ph.D. | Chief Scientific Officer | 571,55k | N/A | 1956 |
Mr. Nicholas Plummer | Group General Counsel | N/A | N/A | 1971 |
Ms. Louise Batchelor Day | Group Chief Marketing & Communications Officer | N/A | N/A | 1972 |
Mr. Thomas Bygott | Sales & Marketing Director | N/A | N/A | N/A |
Mr. Gael Forterre M.B.A. | Chief Commercial Officer | N/A | N/A | 1982 |
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
VolitionRx Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.